Investigation of a mumps outbreak in Mongolia, January to April 2011
Introduction: The Gurvantes district in Omnogovi Province reported a suspected mumps outbreak to the Mongolia Ministry of Health in March 2011. An outbreak investigation team was established to verify the diagnosis and to determine the magnitude of the outbreak.
Methods: The descriptive study comprised retrospective investigation of local hospital medical records and surveillance data, and interviews with school teachers, doctors, probable cases and their close contacts. The World Health Organization standard case definition was used to define mumps cases. Clinical specimens were collected for laboratory confirmation.
Results: There were 153 cases, none under two years of age, with the five- to 14-years-old age group having the highest rates. There was no difference by sex (P = 0.12). A single index case appeared to be the source of the outbreak, and there were four outbreak waves. Of the 129 cases with information on epidemiological links, 94 (72.3%) were linked to other cases at a kindergarten or school, 17 (13%) were from secondary spread of family members, two (1.5%) were from secondary spread of other relatives, and 16 had no established links. Eight cases (5.2%) were confirmed through laboratory investigation.
Conclusion: This was the first high-magnitude mumps outbreak since the introduction of the measles-mumps-rubella vaccine in Mongolia in September 2009. There were no cases among vaccinated children; cases were seen among older children and adults not eligible for the vaccine. This suggests that immunity to mumps is still low in Mongolia. Future outbreaks may occur among this unvaccinated population.
How to Cite
© World Health Organization (WHO) 2022. Some rights reserved.
The articles in this publication are published by the World Health Organization and contain contributions by individual authors. The articles are available under the Creative Commons Attribution 3.0 IGO license (CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. In any use of these articles, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted.
The World Health Organization does not necessarily own each component of the content contained within these articles and does not therefore warrant that the use of any third-party-owned individual component or part contained in the articles will not infringe on the rights of those third parties. The risk of claims resulting from such infringement rests solely with you. If you wish to re-use a component of the articles attributed to a third party, it is your responsibility to determine whether permission is needed for that re-use and to obtain permission from the copyright owner. Examples of components can include, but are not limited to, tables, figures or images.
Any mediation relating to disputes arising under this license shall be conducted in accordance with the WIPO Mediation Rules (www.wipo.int/amc/en/mediation/rules). Any inquiries should be addressed to firstname.lastname@example.org.
License to publish
Western Pacific Surveillance and Response is an open access journal and requires each author of a contribution to grant the World Health Organization (the Publisher) a non-exclusive, worldwide, royalty-free license under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode) for the term of copyright and any extensions thereof. This includes to publish, re-publish, transmit, sell, distribute and otherwise use the article in the Journal, in whole or as a part. This is done by signing the WPSAR License to publish form.
The designations employed and the presentation of the information on this website do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
Links to third-party websites
The World Health Organization does not warrant that the information contained on the website is complete and correct and shall not be liable whatsoever for any damages incurred as a result of its use.